risperidone has been researched along with Encephalopathy, Toxic in 9 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Among AAPDs, risperidone (RIS) ranked third after olanzapine (OLZ) and quetiapine (QUE) used during pregnancy, as OLZ is associated to substantial weight gain in adults and offspring." | 3.83 | Effects of prenatal exposure to antipsychotic risperidone on developmental neurotoxicity, apoptotic neurodegeneration and neurobehavioral sequelae in rat offspring. ( Singh, KP; Singh, M; Singh, MK, 2016) |
| "A patient of bipolar disorder, who presented with manic symptoms with psychotic feature, started with a combination of lithium and risperidone." | 3.74 | Encephalopathy with combined lithium-risperidone administration. ( Boora, K; Hyatt, J; Xu, J, 2008) |
| "Although the risk of developing lethal neuroleptic malignant syndrome may be diminished with atypical drugs, clinicians must remain alert to the signs of this disorder." | 2.41 | Movement disorders associated with atypical antipsychotic drugs. ( Campbell, EC; Caroff, SN; Mann, SC; Sullivan, KA, 2002) |
| "Differential diagnosis between neuroleptic malignant syndrome (NMS) and serotonin syndrome (SS) could not be accurately determined because of the overlap of signs and symptoms of both syndromes." | 1.31 | Neurotoxic syndrome associated with risperidone and fluvoxamine. ( Beddingfield, JJ; Mack, JE; Reeves, RR, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goyal, R | 1 |
| Ali, Y | 1 |
| Singh, KP | 1 |
| Singh, MK | 1 |
| Singh, M | 1 |
| Kozicky, JM | 1 |
| Torres, IJ | 1 |
| Bond, DJ | 1 |
| Lam, RW | 1 |
| Yatham, LN | 1 |
| Park, CH | 1 |
| Park, TW | 1 |
| Yang, JC | 1 |
| Lee, KH | 1 |
| Huang, GB | 1 |
| Tong, Z | 1 |
| Park, MS | 1 |
| Chung, YC | 1 |
| Böker, H | 1 |
| Brandenberger, M | 1 |
| Schopper, C | 1 |
| Boora, K | 1 |
| Xu, J | 1 |
| Hyatt, J | 1 |
| Kontaxakis, VP | 1 |
| Havaki-Kontaxaki, BJ | 1 |
| Stamouli, SS | 1 |
| Christodoulou, GN | 1 |
| Reeves, RR | 1 |
| Mack, JE | 1 |
| Beddingfield, JJ | 1 |
| Caroff, SN | 1 |
| Mann, SC | 1 |
| Campbell, EC | 1 |
| Sullivan, KA | 1 |
1 review available for risperidone and Encephalopathy, Toxic
| Article | Year |
|---|---|
Movement disorders associated with atypical antipsychotic drugs.
Topics: Akathisia, Drug-Induced; Antipsychotic Agents; Benzodiazepines; Clozapine; Dyskinesia, Drug-Induced; | 2002 |
1 trial available for risperidone and Encephalopathy, Toxic
| Article | Year |
|---|---|
No negative symptoms in healthy volunteers after single doses of amisulpride, aripiprazole, and haloperidol: a double-blind placebo-controlled trial.
Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Cognitive Dysfunction; Dizziness; Double-Bli | 2012 |
7 other studies available for risperidone and Encephalopathy, Toxic
| Article | Year |
|---|---|
Severe neurotoxicity associated with low-level serum lithium and risperidone after 25 years of uncomplicated lithium therapy.
Topics: Drug Synergism; Humans; Lithium; Lithium Compounds; Male; Middle Aged; Neurotoxicity Syndromes; Risp | 2014 |
Effects of prenatal exposure to antipsychotic risperidone on developmental neurotoxicity, apoptotic neurodegeneration and neurobehavioral sequelae in rat offspring.
Topics: Age Factors; Analysis of Variance; Animals; Animals, Newborn; Annexin A5; Antipsychotic Agents; Apop | 2016 |
Comparison of neuropsychological effects of adjunctive risperidone or quetiapine in euthymic patients with bipolar I disorder.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Attention; Bipolar Disorder; British Columbia; Diagno | 2012 |
[Neurotoxicity related to lithium-risperidon combination treatment in a patient with schizoaffective disorder].
Topics: Antimanic Agents; Antipsychotic Agents; Cognition Disorders; Drug Interactions; Drug Therapy, Combin | 2007 |
Encephalopathy with combined lithium-risperidone administration.
Topics: Aged; Antipsychotic Agents; Bipolar Disorder; Drug Therapy, Combination; Electroencephalography; Hum | 2008 |
Toxic interaction between risperidone and clozapine: a case report.
Topics: Adult; Antipsychotic Agents; Clozapine; Diagnosis, Differential; Drug Interactions; Humans; Male; Ne | 2002 |
Neurotoxic syndrome associated with risperidone and fluvoxamine.
Topics: Adult; Antipsychotic Agents; Drug Interactions; Female; Fluvoxamine; Humans; Neuroleptic Malignant S | 2002 |